ECHOCARDIOGRAPHY
Evaluation of cardioprotective effects of recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography
Alexander Hansen, MD ,*,
Anjali Kumar, PhD*,
David Wolf, BS ,
Kamilla Frankenbergerova, BS ,
Arthur Filusch, MD ,
Marie-Luise Gross, MD ,
Sebastian Mueller, MD ,
Hugo Katus, MD and
Helmut Kuecherer, MD
* Wyeth Research, Cambridge, Massachusetts, USA
Cardiology
Pathology, University of Heidelberg, Heidelberg, Germany
Manuscript received February 9, 2004;
revised manuscript received April 22, 2004,
accepted May 2, 2004.
* Reprint requests and correspondence: Dr. Alexander Hansen, Department of Cardiology, University of Heidelberg, Bergheimerstr. 58, 69115 Heidelberg, Germany
(Email: alexander_hansen{at}med.uni-heidelberg.de).
OBJECTIVES: The purpose was to examine the cardioprotective effects of recombinant P-selectin glycoprotein ligand-immunoglobulin (rPSGL-Ig) in ischemia-reperfusion injury by real-time myocardial contrast echocardiography (MCE).
BACKGROUND: P-selectin mediates leukocyte recruitment into areas of inflammation.
METHODS: Sixteen pigs underwent 45 min of left anterior descending coronary artery occlusion followed by reperfusion and received rPSGL-Ig or vehicle. To assess changes in myocardial perfusion (A x ß), MCE was performed.
RESULTS: After 120 min of reperfusion, A x ß in the risk area was higher (0.84 ± 0.15 dB/s vs. 0.28 ± 0.1 dB/s, p < 0.0001), and the infarct size was lower (30.3 ± 12% vs. 57 ± 14%, p = 0.002) in the rPSGL-Ig group compared with the vehicle group.
CONCLUSIONS: Recombinant PSGL-Ig improved postischemic reflow accurately detected by real-time MCE.
|
Abbreviations and Acronyms
| | A x ß = myocardial perfusion | | FAS = fractional area shortening | | LAD = left anterior descending coronary artery | | LV = left ventricle | | MBF = myocardial blood flow | | MCE = myocardial contrast echocardiography | | PSGL-1 = P-selectin glycoprotein ligand-1 | | rPSGL-Ig = recombinant P-selectin glycoprotein ligand-immunoglobulin |
|
This article has been cited by other articles:

|
 |

|
 |
 
G Korosoglou, A Hansen, R Bekeredjian, A Filusch, S Hardt, D Wolf, D Schellberg, H A Katus, and H Kuecherer
Usefulness of myocardial parametric imaging to evaluate myocardial viability in experimental and in clinical studies
Heart,
March 1, 2006;
92(3):
350 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Weyman
The year in echocardiography
J. Am. Coll. Cardiol.,
February 1, 2005;
45(3):
448 - 455.
[Full Text]
[PDF]
|
 |
|
|